Cargando…
Safety and efficacy of S1 monotherapy or combined with nab-paclitaxel in advanced elderly pancreatic cancer patients: A meta-analysis
OBJECTIVE: To evaluate the therapeutic efficacy and safety of S1 monotherapy or combination with nab-paclitaxel for the treatment of elderly patients with metastatic or locally advanced pancreatic adenocarcinoma. METHOD: PubMed, Embase, Cochrane Central Library, China Biology Medicine, and China Nat...
Autores principales: | Chen, Yunlong, Gu, Jiangning, Yin, Menghong, Wang, Chenqi, Chen, Dan, Yang, Lili, Chen, Xiang, Lin, Zhikun, Du, Jian, Cui, Shimeng, Ma, Chi, Luo, Haifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238291/ https://www.ncbi.nlm.nih.gov/pubmed/34160399 http://dx.doi.org/10.1097/MD.0000000000026342 |
Ejemplares similares
-
Efficacy of weekly paclitaxel for the treatment of advanced ovarian cancer: A protocol for systematic review and meta-analysis
por: Zhao, Dong-xu, et al.
Publicado: (2020) -
Efficacy of paclitaxel, carboplatin, and bevacizumab for cervical cancer: A protocol for systematic review and meta-analysis
por: Zhang, Li, et al.
Publicado: (2020) -
Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab−Paclitaxel and Maintenance Monotherapy with nab−Paclitaxel: Two Case Reports
por: Araya, Tomoyuki, et al.
Publicado: (2020) -
Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022) -
nab-Paclitaxel for the treatment of pancreatic cancer
por: Kim, George
Publicado: (2017)